Fetal |
Cultured rat fetal astrocytes |
75 mM |
Cultured astrocytes |
Decreased DNMT activity, decreased methylation of tPA promoter, decreased DNMT3a protein |
Zhang et al., 2014 |
Fetal |
Cultured mouse fetal cortical neurons |
75 mM, 5 days |
Cultured neurons |
Demethylation of NR2B gene |
Marutha Ravindran & Ticku, 2004 |
Fetal |
Cultured mouse fetal cortical neurons |
75 mM, 5 days for chronic intermittent ethanol paradigm |
Cultured neurons |
Demethylation of NR2B gene |
Qiang et al., 2010 |
Fetal |
Mouse, cultured embryo |
Dose: 88 mM |
Cultured embryo |
Altered methylation in many genes involved in metabolism, neural development, imprinting |
Liu et al., 2009 |
Fetal |
Mouse, cultured neurospheres |
Dose: 13 mM, 26 mM, 70 mM |
Cultured neurospheres |
Altered activating and repressive histone marks (H3K4me3 and H3K27me3) on genes involved in neural precursor identity and neurogenesis |
Veazey et al., 2013 |
Fetal |
Cultured mouse fetal cortical neurospheres |
13 mM or 70 mM EtOH |
Cultured neurospheres |
High dose suppressed miR-21, -335, -9, and -153; Low dose increased miR-335 |
Sathyan et al., 2007 |
Fetal |
Mouse, Gestational day 9–11 |
Dose: 3 g/kg |
Somatic embryo |
DNA hypomethylation, lower methylase activity |
Garro et al., 1991 |
Fetal |
Mice, Gestational day 9 |
Dose: 5.8 g/kg EtOH |
Somatic embryo |
Subtle decrease in methylation of Igf2 locus with EtOH |
Downing et al., 2011 |
Fetal |
Mouse, Gestational day 6–15 |
BEC: ≥0.4 μg/mL EtOH |
Brain |
Upregulation of many miRNAs, including, miR-10a, miR-10b, miR-9 with EtOH; Downregulation of many miRNAs, including miR-200a, miR-496, miR-296 with EtOH |
Wang et al., 2009 |
Fetal |
Mouse, Gestational Day 0.5–8.5 |
Dose: ~12 g/kg/day |
Brain (hippocampus) |
Altered miRNAs expression of miR138-2, miR290, miR16-2; Altered site specific methylation of several CpG islands |
Marjonen et al., 2015 |
Fetal |
Mouse and Rat, Gestational day 6–15 |
Dose: 0.5, 1, 2, 4 and 6 g/kg/day |
Brain |
Decreased MeCP2 in prefrontal cortex and striatum |
Kim et al., 2013 |
Fetal |
Rat, Gestational day 8–21 |
Dose: 5% w/v EtOH, 35% ethanol-derived calories |
Brain (hippocampus and cortex) |
Altered imprinting patterns and expression of Dio3 |
Sittig et al., 2011 |
Fetal |
Mouse, Gestational day 7–16 |
BEC: 120–160 mg/dL |
Brain (hippocampus) |
Altered methylation program during development in hippocampus, decreased Mecp2 and Tet1 |
Chen et al., 2013 |
Fetal |
Rats, Gestational day 7–21 |
Dose: 6.7% EtOH (v/v), BEC: ~110–120 mg/dL |
Brain (hypothalamus) in Pomc cells |
Increased MeCP2 protein and DNA binding to Pomc gene |
Gangisetty et al., 2014 |
Neonatal |
Rats, postnatal days 2–12 |
BEC: 30–80 mM |
Brain (cerebellum) |
Reduced CREB binding protein, reduced H3 and H4 acetylation with EtOH exposure |
Guo et al., 2011 |
Fetal and preconception |
Mouse; Fetal: gestational Day 0.5–8.5; Preconception: 4 days/week for 10 weeks |
Dose: 10% EtOH (v/v), ~12 g/kg/day |
Tail |
Hypermethylation of the Agouti mutation (Avy) locus and transcriptional silencing of the gene |
Kaminen-Ahola et al., 2010 |
Fetal (F1) exposure, F1–3 generations |
Rats, Gestational day 7–21 |
Dose: 6.7% EtOH (v/v), BEC: ~110–120 mg/dL |
Brain (hypothalamic neurons), sperm |
Increased methylation of the Pomc gene promoter in hypothalamus and sperm cells in F1-F3 offspring |
Govorko et al., 2012; Bekdash et al., 2013
|
Fetal (F1) exposure, F2 offspring |
Mouse, Gestational day 10–18 |
Dose: 0.5 g/kg/day EtOH |
Sperm, brain |
Decrease in methylation of H19 gene in sperm of exposed F1 offspring, Decrease in methylation of H19 gene in brain of F2 offspring |
Stouder et al., 2011 |
Human children |
Human children with FASD and healthy control children |
Not reported |
Buccal epithelial cells |
658 differentially methylated sites in FASD children compared to controls, overlapping with 95 different genes; increased methylation on genes relevant to neurodevelopment |
Portales-Casamar et al., 2016 |